Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2017

Open Access 01-12-2017 | Research article

Predictors of long term use of psychiatric services of patients with recent-onset schizophrenia: 12 years follow-up

Authors: Víðir Sigrúnarson, Rolf W. Gråwe, Stian Lydersen, Gunnar Morken

Published in: BMC Psychiatry | Issue 1/2017

Login to get access

Abstract

Background

The aim of study was to investigate predictors of long term use of psychiatric services of patients with recent-onset schizophrenia.

Methods

A cohort of 50 clinically stable patients with recent-onset schizophrenia was included in a randomized controlled trial comparing early integrated treatment with treatment as usual. Recent onset was defined as emergence of psychotic symptoms for the first time during the preceding 2 years. The follow up period was from the date of randomization and until 12 years after termination of treatment trial, 14 years forward.

Results

Score on Brief psychiatric rating scale both at baseline and after 2 years of treatment, suicide attempts during 2 years of treatment and being an inpatient during 2 years of treatment were significant predictors of long term use of services.

Conclusion

High score on Brief psychiatric rating scale, suicide attempts and being admitted as inpatient early in the course of schizophrenia are possible predictors of long term use of services.

Trial registration

ClinicalTrials.gov NCT00184509. Registered 15 September 2005.
Appendix
Available only for authorised users
Literature
1.
Haro J, Novick D, Suarez D, Ochoa S, Roca M. Predictors of the course of illness in outpatients with schizophrenia: a prospective three year study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32(5):1287–92.CrossRef
2.
Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry. 2001;50(11):884–97.CrossRefPubMed
3.
Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry. 2005;62(3):247.CrossRefPubMed
4.
Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123.CrossRefPubMed
5.
6.
Thara R. Twenty-year course of schizophrenia: the Madras Longitudinal Study. Can J Psychiatry. 2004;49:564–9.CrossRefPubMed
7.
Bird V, Premkumar P, Kendall T, Whittington C, Mitchell J, Kuipers E. Early intervention services, cognitive–behavioural therapy and family intervention in early psychosis: systematic review. Br J Psychiatry. 2010;197:350–6.CrossRefPubMedPubMedCentral
8.
Almond S, Knapp M, Francois C, Toumi M, Brugha T. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry. 2004;184(4):346–51.CrossRefPubMed
9.
10.
Ascher-Svanum H, Zhu B, Faries D, Salkever D, Slade E, Peng X, Conley R. The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry. 2010;10(1):2.CrossRefPubMedPubMedCentral
11.
Grawe RW, Falloon IRH, Widen JH, Skogvoll E. Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study. Acta Psychiatr Scand. 2006;114(5):328–36.CrossRefPubMed
12.
Morken G, Widen JH, Grawe RW. Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia. BMC Psychiatry. 2008;8(1):32.CrossRefPubMedPubMedCentral
13.
Morken G, Grawe RW, Widen JH. Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia. J Clin Psychiatry. 2007;68(4):566–71.CrossRefPubMed
14.
Sigrúnarson V, Gråwe RW, Morken G. Integrated treatment vs. treatment-as-usual for recent onset schizophrenia; 12 year follow-up on a randomized controlled trial. BMC Psychiatry. 2013;13:200. doi:10.​1186/​1471-244X-13-200. PubMed PMID: 23898805; PubMed Central PMCID: PMC3733816.
15.
Association AP. Diagnostic and statistical manual of mental disorders DSM-IV. 4th ed. 1994.
16.
Lukoff D, Liberman RP, Nuechterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull. 1986;12(4):578–602.CrossRefPubMed
17.
Falloon IR, Boyd JL, McGill CW, Razani J, Moss HB, Gilderman AM. Family management in the prevention of exacerbations of schizophrenia: a controlled study. N Engl J Med. 1982;306(24):1437–40.CrossRefPubMed
18.
Anderson SW, Crist AJ, Payne N. Predicting inpatient length of stay with the expanded version of the brief psychiatric rating scale (Version 4.0). Psychiatr Serv. 2004;55(1):77–9.CrossRefPubMed
19.
Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–9.CrossRefPubMed
20.
Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710–8.CrossRefPubMed
21.
Sun G-W, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996;49(8):907–16.CrossRefPubMed
22.
Rabinowitz J, Levine SZ, Häfner H. A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophr Res. 2006;88(1–3):96–101.CrossRefPubMed
23.
Angermeyer MC, Kühn L, Goldstein JM. Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull. 1990;16(2):293.CrossRefPubMed
24.
Averill P, Hopko D, Small D, Greenlee H, Varner R. The role of psychometric data in predicting inpatient mental health service utilization. Psychiatry Q. 2001;72(3):215–35.CrossRef
25.
Mortensen PB, Eaton W. Predictors for readmission risk in schizophrenia. Psychol Med. 1994;24(01):223–32.CrossRefPubMed
26.
Hillard JR, Slomowitz M, Deddens J. Determinants of Emergency Psychiatric Admission for adolescents and adults. Am J Psychiatry. 1988;145(11):1416–9.CrossRefPubMed
27.
Tabachnick BG. Fidell LS. Using multivariate statistics: Osterlind SJ; 2001.
28.
Averill PM, Hopko DR, Small DR, Greenlee HB, Varner RV. The role of psychometric data in predicting inpatient mental health service utilization. Psychiatry Q. 2001;72(3):215–35.CrossRef
29.
Hopko DR, Lachar D, Bailley SE, Varner RV. Assessing predictive factors for extended hospitalization at acute psychiatric admission. Psychiatr Serv. 2001;52(10):1367–73.CrossRefPubMed
30.
Jaaskelainen E, Haapea M, Rautio N, Juola P, Penttila M, Nordstrom T, Rissanen I, Husa A, Keskinen E, Marttila R, et al. Twenty Years of Schizophrenia Research in the Northern Finland Birth Cohort 1966: A Systematic Review. Schizophrenia research and treatment. 2015;2015:524875.CrossRefPubMedPubMedCentral
31.
Tatarelli-roberto R. Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry. 2007;6:10.CrossRef
32.
33.
Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry. 2005;187(1):9–20.CrossRefPubMed
34.
De Hert M, McKenzie K, Peuskens J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr Res. 2001;47(2–3):127–34.CrossRefPubMed
35.
Abel KM, Drake R, Goldstein JM. Sex differences in schizophrenia. Int Rev Psychiatry. 2010;22(5):417–28.CrossRefPubMed
36.
Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. A J Psychiatry. 1995;152(5):698–703.CrossRef
37.
Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res. 1999;0(0):S93–100.CrossRef
38.
Austin SF, Mors O, Secher RG, Hjorthoj CR, Albert N, Bertelsen M, Jensen H, Jeppesen P, Petersen L, Randers L, et al. Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up. Schizophr Res. 2013;150(1):163–8.CrossRefPubMed
39.
Revier CJ, Reininghaus U, Dutta R, Fearon P, Murray RM, Doody GA, Croudace T, Dazzan P, Heslin M, Onyejiaka A, et al. Ten-Year Outcomes of First-Episode Psychoses in the MRC AESOP-10 Study. J Nerv Ment Dis. 2015;203(5):379–86.CrossRefPubMedPubMedCentral
40.
Häfner H, an der Heiden W. The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies. Eur Arch Psychiatry Clin Neurosci. 1999;249(4):S14–26.CrossRef
41.
Metadata
Title
Predictors of long term use of psychiatric services of patients with recent-onset schizophrenia: 12 years follow-up
Authors
Víðir Sigrúnarson
Rolf W. Gråwe
Stian Lydersen
Gunnar Morken
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2017
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-016-1186-x

Other articles of this Issue 1/2017

BMC Psychiatry 1/2017 Go to the issue

Research article

Reduced functional connectivity between bilateral precuneus and contralateral parahippocampus in schizotypal personality disorder

Research article

A pilot study on feasibility, acceptance and effectiveness of metacognitive-oriented social skills training in schizophrenia

Research article

Longitudinal trends in self-reported anxiety. Effects of age and birth cohort during 25 years

Study protocol

Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder

Research article

Altered fractional amplitude of low frequency fluctuation associated with cognitive dysfunction in first-episode drug-naïve major depressive disorder patients

Research article

A prospective, quantitative study of mental health act assessments in England following the 2007 amendments to the 1983 act: did the changes fulfill their promise?